HMGA2 as a prognostic and immune biomarker in hepatocellular carcinoma: Comprehensive analysis of the HMG family and experiments validation
Open Access
- 26 November 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (11) , e0311204
Abstract
The molecular mechanisms underlying hepatocellular carcinoma (HCC) are complex and not fully understood. This study aims to explore the expression and clinical significance of High Mobility Group (HMG) proteins in HCC to identify potential prognostic biomarkers and therapeutic targets. Bioinformatic analyses were performed using data from The Cancer Genome Atlas (TCGA) and other databases. Expression levels of HMGs were validated in HCC cell lines using qRT-PCR, and functional studies were conducted by knocking down HMGA2.HMG family members, particularly HMGA1, HMGA2, HMGB2, and HMGN1, were significantly upregulated in HCC tissues compared to normal tissues. High expression levels of these proteins were associated with poor overall survival and disease-specific survival in HCC patients. Knockdown of HMGA2 in HCC cell lines led to reduced cell proliferation, migration, and invasion. HMGA2, along with other HMG family members, emerges as a potential prognostic biomarker and therapeutic target in HCC. This study provides new insights into the role of HMG proteins in HCC progression.Keywords
Funding Information
- the national key Research and Development Program of China (2020YFC2008904)
This publication has 41 references indexed in Scilit:
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- HMGB1 Develops Enhanced Proinflammatory Activity by Binding to CytokinesThe Journal of Immunology, 2008
- Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver diseaseWorld Journal of Gastroenterology, 2008
- HMG chromosomal proteins in development and diseaseTrends in Cell Biology, 2007
- Functional genomics analysis of low concentration of ethanol in human hepatocellular carcinoma (HepG2) cells. Role of genes involved in transcriptional and translational processesInternational Journal of Medical Sciences, 2007
- Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transitionJournal of Cell Biology, 2006
- Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancerFEBS Letters, 2004
- Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatinThe EMBO Journal, 2003
- Role of the high mobility group A proteins in human lipomasCarcinogenesis, 2001
- Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal ProteinsMolecular and Cellular Biology, 1999